Please Wait
Applying Filters...
menu
    • menu
    Coral

    Virtual Booth

    Contact Supplier

    China’s top API & intermediate manufacturer, delivering advanced CMO/CDMO solutions to 60+ countries, empowering global health progress

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Alchem offers Botanical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    Masitinib

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    AB Science Posts Masitinib Survival Benefits in ALS
    AB Science Posts Masitinib Survival Benefits in ALS

    20 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/20/3277390/0/en/ab-science-new-publication-on-medrxiv-demonstrating-substantial-survival-benefits-and-preserved-quality-of-life-with-masitinib-in-als-patients.html

    GLOBENEWSWIRE
    20 Apr 2026
    Share Share
    AB Science Secures US Patent For Masitinib In Sickle Cell
    AB Science Secures US Patent For Masitinib In Sickle Cell

    27 Dec 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/news/ab-science-secures-us-patent-for-masitinib-in-sickle-cell-disease-till-2040-18698

    INDPHARMAPOST
    27 Dec 2025
    Share Share
    AB Science Gets FDA, EMA OK for Masitinib Prostate Trial
    AB Science Gets FDA, EMA OK for Masitinib Prostate Trial

    05 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/04/3110206/0/en/AB-Science-Masitinib-receives-FDA-and-EMA-authorization-for-confirmatory-phase-3-trial-in-metastatic-castrate-resistant-prostate-cancer.html

    GLOBENEWSWIRE
    05 Jul 2025
    Share Share
    AB Science gets Chinese patent for masitinib in Covid-19
    AB Science gets Chinese patent for masitinib in Covid-19

    19 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/19/3083680/0/en/AB-Science-receives-Chinese-patent-protecting-masitinib-in-the-treatment-of-Covid-19-until-2041-adding-one-more-indication-with-long-term-intellectual-property-protection.html

    GLOBENEWSWIRE
    19 May 2025
    Share Share
    AB Science: PLOS One Publishes Masitinib Neuroprotective Data
    AB Science: PLOS One Publishes Masitinib Neuroprotective Data

    15 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/15/3081812/0/en/AB-Science-today-reports-a-new-publication-in-the-scientific-journal-PLOS-One-showing-promising-neuroprotective-effects-of-masitinib.html

    GLOBENEWSWIRE
    15 May 2025
    Share Share
    AB Science gets US patent for masitinib until 2040 for sickle cell
    AB Science gets US patent for masitinib until 2040 for sickle cell

    14 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/14/3061150/0/en/AB-Science-receives-notice-of-allowance-for-Unites-States-patent-covering-masitinib-until-2040-in-the-treatment-of-sickle-cell-disease.html

    GLOBENEWSWIRE
    14 Apr 2025
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.